Rachel E. Haurwitz
Rachel E. Haurwitz's purchase track record
Rachel E. Haurwitz has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/14/2025 | CRBU | $20K | +9.9% | +78.2% | +16.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced. Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.
Transaction History
| CRBU | ▲ Buy | Grant | 151,700 | $0 | 2/20/2026 | View on chart |
| CRBU | ▲ Buy | Open Market | 20,000 | $20K | 3/14/2025 | View on chart |
| CRBU | ▲ Buy | Grant | 136,750 | $0 | 2/20/2025 | View on chart |
| SEER | ▲ Buy | Grant | 58,178 | $0 | 6/12/2024 | View on chart |
| CRBU | ▲ Buy | Grant | 118,700 | $0 | 2/20/2024 | View on chart |
| SEER | ▲ Buy | Grant | 23,443 | $0 | 6/14/2023 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 10,000 | $30K | 6/8/2023 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 10,000 | $30K | 3/20/2023 | View on chart |
| SEER | ▲ Buy | Grant | 5,994 | $0 | 6/15/2022 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 10,000 | $30K | 5/9/2022 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 10,000 | $30K | 1/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
No recent news for Caribou Biosciences (CRBU)
There are no recent news releases specifically about Caribou Biosciences in the past week. The stock remains unchanged in terms of public announcements. Technical indicators show RSI at 35.1 and support around $1.59, but without new information the market context is limited.
No recent news for Caribou Biosciences (CRBU). There are no recent news releases specifically about Caribou Biosciences in the past week. The stock remains unchanged in terms of public announcements. Technical indicators show RSI at 35.1 and support around $1.59, but without new information the market context is limited.